# Poly Medicure Ltd (POLYMED)
> Exchange: NSE | Sector: Healthcare | ISIN: 

## Price
Current Price: ₹1598.2
Day Change: +3.07%
52W High: ₹2529.9
52W Low: ₹1182
Market Cap: ₹14,769 Cr

## Valuation
P/E: 42.59
P/B: 5.06
EPS: ₹34.17
Book Value: ₹287.91
Dividend Yield: 0%

## Returns
1Y Return: -17.74%

## Profitability
ROE: 0%
ROCE: 30.76%
Debt/Equity: 0.08
Revenue Growth: 16.4%
Profit Growth: -17.6%
EBITDA Margin: 25.22%
Operating Margin: 16.7%

## About
Poly Medicure Ltd is a Medical Instruments & Supplies company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Healthcare
Industry: Medical Instruments & Supplies
Sub Industry: Unknown

## Business Model
Overview: Poly Medicure Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Medical Instruments & Supplies. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Healthcare.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Monitoring Agency Report
- Announcement: Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 25Th May, 2026
- BSE Filing: Announcement under Regulation 30 (LODR)-Monitoring Agency Report

## Access
Current tier: anonymous
More history: Register free to see 9 more years.

## Data Freshness
Quote Updated: 2026-05-24T20:00:14.480Z
Price History Updated: 2026-05-25T05:29:24.880Z
Latest Price History Date: 2026-05-24
Technicals Updated: 2026-05-25T05:29:24.880Z
Quant Updated: 2026-05-25T05:29:24.880Z
Sentiment Updated: 2026-05-25T05:29:24.880Z
Financials Status: current
Financials Updated: 2026-05-18T09:32:00.005Z
Financials Last Attempt: 2026-05-18T09:32:00.005Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Mar 2015)
Revenue: ₹322 Cr
Operating Profit: ₹76 Cr (OPM 24%)
Net Profit: ₹45 Cr
Tax: ₹63 Cr

## Annual P&L History
Mar 2015: Rev ₹322Cr | PAT ₹45Cr | OPM 24%
Mar 2016: Rev ₹390Cr | PAT ₹62Cr | OPM 22%
Mar 2017: Rev ₹411Cr | PAT ₹48Cr | OPM 21%

## Balance Sheet (Mar 2015)
Total Assets: ₹286 Cr
Total Liabilities: ₹286 Cr
Borrowings: ₹67 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Himanshu  Baid, CEO, MD & Director
- Jugal Kishore Baid, Founder & Non Executive Director
- Naresh  Vijayvergiya, Chief Financial Officer
- Avinash  Chandra, Company Secretary & Compliance Officer
- Rishi  Baid B.S.M.E, Joint MD & Executive Director

---
Source: rupiya.io/stocks/polymed
Disclaimer: For research and education only. Not investment advice.